EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Botulinum Toxin for Bruxism: An Overview

Manuella Salm Coelho, Júlia Meller Dias de Oliveira, Helena Polmann, Patrícia Pauletto iD, Cristine Miron Stefani, Lara Catarine De Luca Maciel, Graziela De Luca Canto

Toxins · 16.05.2025 · 17 (5) · 249

DOI: 10.3390/toxins17050249 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Toxins, online erschienen am 16.05.2025. Verfasst von Manuella Salm Coelho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Brazilian Centre for Evidence-Based Research (COBE), Department of Dentistry, Federal University of Santa Catarina (UFSC), Florianópolis 88040-535, B…. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Bruxism, Neuromuscular Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research of Santa Catarina (FAPESC), National Council for Scientific and Technological Development (CNPq), Foundation for Support of University Research and Extension (FAPEU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This overview aimed at assessing botulinum toxin type A (BoNT-A)’s effectiveness in managing bruxism compared to a placebo, the absence of treatment, or other interventions in adults. Only systematic reviews (SRs), with or without a meta-analysis, were included. A comprehensive literature search was conducted on 16 June 2024, encompassing seven databases and grey literature sources. Experts and reference lists of the included SRs were also consulted. Study selection was conducted in two phases by two independent authors. Methodological quality was evaluated using AMSTAR-2. Overlap was assessed using the corrected covered area. The 14 included SRs addressed several outcomes. In most studies, BoNT-A showed effectiveness in reducing pain (n = 10), the frequency of bruxism events (n = 7), and the maximum bite force (n = 5). None of the SRs effectively evaluated BoNT-A’s impact on functional movements. All of the included SRs scored “critically low” and “low” confidence rates in AMSTAR-2. Only one SR attempted to assess the certainty of the evidence, although unsuccessfully. The overlap across included SRs was rated as “high”, with a corrected covered area of 10.11%. The current systematic reviews on BoNT-A for bruxism lack methodological quality, limiting the reliability of their findings. Despite evidence indicating a potential reduction in pain, bruxism events, and the maximum bite force, methodological limitations prevent definitive conclusions from being drawn. High-quality research with standardized methodologies is essential to establish BoNT-A’s efficacy and support evidence-based clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ABruxismNeuromuscular AgentsHumansTreatment OutcomeSystematic Reviews as Topic

Stichwörter der Autor:innen

botulinum toxins type Abruxismevidence-based dentistrymasseter muscleoverviewtemporal muscle

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Brazilian Centre for Evidence-Based Research (COBE), Department of Dentistry, Federal University of Santa Catarina (UFSC), Florianópolis 88040-535, Brazil.
  • Faculty of Dentistry, Universidad de las Americas (UDLA), Quito 170513, Ecuador.
  • Department of Dentistry, University of Brasília, Brasília 70910-900, Brazil.
  • Centre for Cell Biology & Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, UK.
  • Emergency Medicine and Evidence-Based Medicine, Federal University of São Paulo, São Paulo 040023-062, Brazil.

ORCID-Profile: Patrícia Pauletto

Förderung

  • Foundation for Research of Santa Catarina (FAPESC)
  • National Council for Scientific and Technological Development (CNPq)
  • Foundation for Support of University Research and Extension (FAPEU)

Zitieren

APA

Coelho, M. S., Oliveira, J. M. D., Polmann, H., Pauletto, P., Stefani, C. M., Maciel, L. C. L., & Canto, G. L. (2025). Botulinum Toxin for Bruxism: An Overview. Toxins, 17(5), 249. https://doi.org/10.3390/toxins17050249

Vancouver

Coelho MS, Oliveira JMD, Polmann H, Pauletto P, Stefani CM, Maciel LCL, et al. Botulinum Toxin for Bruxism: An Overview. Toxins. 2025;17(5):249. doi:10.3390/toxins17050249

BibTeX
@article{Coelho2025,
  author = {Coelho, Manuella Salm and Oliveira, Júlia Meller Dias de and Polmann, Helena and Pauletto, Patrícia and Stefani, Cristine Miron and Maciel, Lara Catarine De Luca and Canto, Graziela De Luca},
  title = {Botulinum Toxin for Bruxism: An Overview},
  journal = {Toxins},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {249},
  doi = {10.3390/toxins17050249}
}
Kostenlos starten →